Fosun Pharma Rumored To Slash HK IPO To $800 Million
This article was originally published in PharmAsia News
Executive Summary
Following its announcement of authorities’ approval for listing in Hong Kong on April 11, Shanghai Fosun Pharmaceutical (Group) Co. Ltd. was rumored to have scheduled the listing for this quarter, with a slashed IPO scale of $800 million from $1 billion.